News & events

Press Releases

On the 28th March 2022, OncoArendi changed its name to Molecure

Invitation to tender

6 March 2014

OncoArendi Therapeutics has signed an exclusive agreement

30 January 2014

OncoArendi Therapeutics has closed its angel investment round raising

21 January 2014

OncoArendi has signed a contract agreement with the Polish Agency for Enterprise Development

5 November 2013

The Nencki Institute of Experimental Biology has just signed

6 June 2013

A patent application for the OAT-449

9 April 2013

Events & Presentations

ESMO – 8-12 September 2017 Madrid

1 September 2017

ERS – 9-13 September 2017 Milan

1 September 2017

BIO USA – San Diego 19-22 June 2017

1 June 2017

ATS – Washington 19-24 May 2017

1 May 2017